Severe asthma is a collection of disease entities with varying pathophysiological characteristics (7) that result in symptoms of cough, wheeze and breathlessness, with frequent exacerbations. To address the problem of phenotypic difference and heterogeneity, the Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes (U-BIOPRED) project was set up as a public-private partnership within the framework of the Innovative Medicines Initiative (IMI), engaging academia, the pharmaceutical industry and patient groups. The goal of this investigation was to identify transcript fingerprints in whole blood that characterize patients with severe asthma and to determine whether subgroups of severe asthmatics can be identified. Furthermore, we were interested in elucidating the biological pathways that showed differences between subgroups.
A Severe Asthma Disease Signature from Gene Expression Profiling of Peripheral Blood from U-BIOPRED Cohorts.
Sex, Specimen part, Race
View SamplesThis SuperSeries is composed of the SubSeries listed below.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Sex, Specimen part, Time
View SamplesTo explore the psoriasis phenotype and pathways involved in psoriasis, we characterized gene expression in lesional and non-lesional skin from psoriasis patients. Furthermore, we explored the effects of various doses of brodalumab on lesional skin over time.
Gene expression profiles normalized in psoriatic skin by treatment with brodalumab, a human anti-IL-17 receptor monoclonal antibody.
Specimen part, Disease, Disease stage, Treatment, Subject, Time
View SamplescDNA and cRNA hybridization technologies have different, probe-specific sensitivities. We used samples from an etanercept trial (GSE11903) to explore in a real-life setting the uniqueness of each platform.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Specimen part, Time
View SamplesTo explore the psoriasis phenotype and pathways involved in psoriasis, we characterized gene expression in lesional and non-lesional skin from psoriasis patients.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Specimen part
View SamplesTo explore the psoriasis phenotype, we characterize gene expression in lesional and non-lesional skin from psoriasis patients.
Cross-study homogeneity of psoriasis gene expression in skin across a large expression range.
Sex, Specimen part
View SamplesThis SuperSeries is composed of the SubSeries listed below.
No associated publication
Specimen part, Cell line
View SamplesClassification of tamixifen-treated breast cancer patients into high and low risk groups using the 76-gene signature
The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy.
No sample metadata fields
View SamplesThis SuperSeries is composed of the SubSeries listed below.
The plasma cell signature in autoimmune disease.
Specimen part, Treatment, Time
View SamplesToll-like receptor (TLR)4 agonists are known potent immunostimulatory compounds. These compounds can be formulated as part of novel adjuvants to enhance vaccine medicated immune responses. However, the contribution of the formulation to the innate in vivo activity of TLR4 agonist compounds is not well understood.
No associated publication
Specimen part, Time
View Samples